Sun Pharma has got the Competition Commission of India’s approval to sell the erstwhile Ranbaxy Laboratories’ two divisions in the Central nervous system (CNS) segment...
Sun Pharmaceutical Industries said that it has raised Rs 1,000 crore through issuing non-convertible debentures (NCDs) on private placement basis. It said in a BSE...